Guerbet SA provided revenue guidance for the second half and full year 2023. for the second half, the company expects stronger growth in the second half of the year than in the first, especially with the industrial activity being brought back up to the required level standard in Raleigh and the gradual ramp-up of EluciremTM.
For the full year, the company expects revenue growth of more than 5% on a like-for-like basis and at CER for 2023.